科學諮詢委員會

Plenary Sessions and Overall Program

Steve Yang, Ph.D., Vice President, Head of R&D, Asia, Pfizer Global Research & Development

Tony Zhang, Ph.D., Vice President, Global External R&D, Asia, Eli Lilly & Co.

Xian-Ping Lu, Ph.D., CEO & Chief Scientific Officer, henzhen Chipscreen Biosciences, Ltd.

Kewen Jin, M.D., General Manager, Preclinical Services, Charles River Laboratories Greater China

Li Chen, Ph.D., Chief Executive Officer, Hua Medicine

Clinical & Regulatory Summit

Ruiping Dong, M.D., Ph.D., Senior Vice President, Head of Emerging Markets R&D, Merck Research Laboratories

Maria Song, Ph.D., M.D., R. Pharmacist, M.A., President, VPS-CRO Group

Ling Su, Ph.D., Senior Vice President, Head of Development Greater China, Novartis Pharma

Karen Atkin, M.D., Vice President, R&D, AstraZeneca China

Li Ding, MSc., China Site Head, Clinical Data Management, sanofi-aventis

Frank Shen, Ph.D., Head, Biometrics (Biostatistics & Data Management), Actemra China Development Champion, Roche Global Pharma Development Center, Asia Pacific

Dan Zhang, M.D., MPH, Co-Founder & CEO, Fountain Medical Development

Discovery to PreClinical Development & Partnerships

Seymour Mong, Ph.D., Independent Consultant

Canwen Jiang, M.D., Ph.D., Vice President & Head of R&D China, Genzyme

Zhengyu Yuan, Ph.D., President & CEO, MicuRx Pharmaceuticals, Inc.

Jing Shan (Jennifer) Hu, Ph.D., Director Licensing & External Research, Licensing & External Research, Merck & Co.

Stella Xu, Ph.D., Executive Director, Roche Partnering, Roche (Shanghai) R&D Center

Kewei Wang, Ph.D., M.D., Changjiang Professor, Neurobiology, Neoroscience Research Institute, Peking University School of Medicine

Biologics & Biosimilars Development

Chris Chen, Ph.D., Chief Executive Officer, Shanghai Kanda Biotechnology Co. Ltd.

Guo-Liang Yu, Ph.D., President & CEO, Epitomics. Inc.

Steven Lee, Ph.D., Chief Executive Officer, A-Bio Pharma Pte. Ltd.